Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 722 $ 876
Restricted cash 1,880 860
Accounts and other receivables 369 218
Accounts receivable—related party 2 0
Inventory 243 160
Derivative assets 57 24
Other current assets 96 100
Total current assets 3,369 2,238
Non-current restricted cash 11 91
Property, plant and equipment, net 23,978 20,635
Debt issuance costs, net 149 277
Non-current derivative assets 34 83
Goodwill 77 77
Other non-current assets, net 288 302
Total assets 27,906 23,703
Current liabilities    
Accounts payable 25 49
Accrued liabilities 1,078 637
Current debt 0 247
Deferred revenue 111 73
Derivative liabilities 37 71
Total current liabilities 1,251 1,077
Long-term debt, net 25,336 21,688
Non-current deferred revenue 1 5
Non-current derivative liabilities 19 45
Other non-current liabilities 59 49
Commitments and contingencies (see Note 19)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Common stock, $0.003 par value, Authorized: 480.0 million shares at December 31, 2017 and 2016; Issued: 250.1 million shares at December 31, 2017 and 2016
Outstanding: 237.6 million shares and 238.0 million shares at December 31, 2017 and 2016, respectively 1 1
Treasury stock: 12.5 million shares and 12.2 million shares at December 31, 2017 and 2016, respectively, at cost (386) (374)
Additional paid-in-capital 3,248 3,211
Accumulated deficit (4,627) (4,234)
Total stockholders’ deficit (1,764) (1,396)
Non-controlling interest 3,004 2,235
Total equity 1,240 839
Total liabilities and equity $ 27,906 $ 23,703